Journals / Neurological sciences and neurophysiology (Online) / 2020 / Cilt: 37 - Sayı: 2

Vestibular Migraine: Considered from Both the Vestibular and the Migraine Point of View

Pages
41–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The management is summarized on the basis of mechanism and comorbidity and the importance of prophylactic medication.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A temporal overlap between vestibular symptoms, such as vertigo and head movement intolerance, and migraine symptoms, such as headache, photophobia, and phonophobia, is a requisite diagnostic criterion for the diagnosis of vestibular migraine (VM).
📊
Key Findings & Data:Diagnostic criteria for VM have been proposed by an International Vestibular Research Group (the Bárány Society) and a headache research group (International Headache Society); however, in practice, it is still acceptable to divide patients suspected of VM into “definite VM” and “probable VM” groups.
💡
Conclusion & Impact:The management is summarized on the basis of mechanism and comorbidity and the importance of prophylactic medication.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

A temporal overlap between vestibular symptoms, such as vertigo and head movement intolerance, and migraine symptoms, such as headache, photophobia, and phonophobia, is a requisite diagnostic criterion for the diagnosis of vestibular migraine (VM). Diagnostic criteria for VM have been proposed by an International Vestibular Research Group (the Bárány Society) and a headache research group (International Headache Society); however, in practice, it is still acceptable to divide patients suspected of VM into “definite VM” and “probable VM” groups. Here, a neuro‑otologist and a headache specialist consider VM from their own points of view using four real cases, two from a dizzy clinic and two from a headache clinic, with expert opinions and arguments according to the current literature. The management is summarized on the basis of mechanism and comorbidity and the importance of prophylactic medication.

🔖

Cite This Article

AKDAL, G., ÖZÇELİK, P. K., ÖZGE, A. (2020). Vestibular Migraine: Considered from Both the Vestibular and the Migraine Point of View. Neurological sciences and neurophysiology (Online), Cilt: 37 - Sayı: 2, 41–49. https://ajindex.com/articles/290522

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Bisdorff A, Andrée C, Vaillant M, Sándor PS. Headache‑associated dizziness in a headache population: Prevalence and impact. Cephalalgia 2010;30:815‑20
  2. Akdal G, Ozge A, Ergör G. The prevalence of vestibular symptoms in migraine or tension‑type headache. J Vestib Res 2013;23:101‑6
  3. Akdal G, Baykan B, Ertaş M, Zarifoğlu M, Karli N, Saip S, et al. Population‑based study of vestibular symptoms in migraineurs. Acta Otolaryngol 2015;135:435‑9
  4. Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001;56:436‑41
  5. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): Vestibular migraine? J Neurol 1999;246:883‑92
  6. Sachs OW. Migraine: The Evolution of a Common Disorder. 1st ed. London: Faber & Faber; 1970
  7. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd ed.ition (beta version). Cephalalgia 2013;33:629‑808
  8. Derici Yıldırım D, Taşdelen B, Uludüz D, Özge A, Yoloğlu S. Impact of a new migraine‑specific comorbidity index on prognosis: A methodology study. Neurol Sci Neurophysiol 2018;35:183‑8
  9. Morganti LO, Salmito MC, Duarte JA, Bezerra KC, Simões JC, Ganança FF. Vestibular migraine: Clinical and epidemiological aspects. Braz J Otorhinolaryngol 2016;82:397‑402
  10. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed.ition. Cephalalgia 2018;38:1‑211
  11. Hsu LC, Wang SJ, Fuh JL. Prevalence and impact of migrainous vertigo in mid‑life women: A community‑based study. Cephalalgia 2011;31:77‑83
  12. Inan LE. Greater occipital nerve blockade for the treatment of chronic migraine. Cephalalgia 2016;36:1095
  13. Karadaş Ö, Öztürk B, İnan L, İnan N. Comparison of single and repeated blockade of the greater occipital nerve in migraine treatment. Neurol Sci Neurophysiol 2018;35:97‑101
  14. Neuhauser HK, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, et al. Migrainous vertigo: Prevalence and impact on quality of life. Neurology 2006;67:1028‑33
  15. Lahmann C, Henningsen P, Brandt T, Strupp M, Jahn K, Dieterich M, et al. Psychiatric comorbidity and psychosocial impairment among patients with vertigo and dizziness. J Neurol Neurosurg Psychiatry 2015;86:302‑8
  16. Teggi R, Caldirola D, Colombo B, Perna G, Comi G, Bellodi L, et al. Dizziness, migrainous vertigo and psychiatric d